ÂÜÀòÂÒÂ×

Carrie Hartill currently serves as Executive Director at Geistlich Pharma AG since June 2022, following a successful tenure as Director for the Biomaterials Business Unit in Surgery from August 2017 to June 2022. Prior to joining Geistlich, Carrie held the position of Chief Scientific Officer at RTI Surgical® from October 2001 to January 2017, contributing significant expertise as part of the C-level executive leadership team with a focus on research and development, quality assurance, regulatory affairs, and clinical operations. Additionally, responsibilities included overseeing international expansion in Asia and managing operations in the German subsidiary.